We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+8.83%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$1.17B
AUM Growth
+$284M
Cap. Flow
+$340M
Cap. Flow %
29%
Top 10 Hldgs %
38.67%
Holding
102
New
36
Increased
28
Reduced
14
Closed
19

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$31.2M
2
CAH icon
Cardinal Health
CAH
+$29.2M
3
VERA icon
Vera Therapeutics
VERA
+$28.8M
4
CVS icon
CVS Health
CVS
+$28.1M
5
LLY icon
Eli Lilly
LLY
+$23.2M

Top Sells

Rank Stock Value
1
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
+$35M
2
NVS icon
Novartis
NVS
+$23M
3
THC icon
Tenet Healthcare
THC
+$19.3M
4
ACLX
Arcellx
ACLX
+$15.1M
5
MDT icon
Medtronic
MDT
+$13M

Sector Composition

Rank Sector Weight
1 Healthcare 96.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSM icon
1
Insmed
INSM
$21.4B
$107M 9.12%
1,550,000
+100,000
+7% +$7.2M
THC icon
2
Tenet Healthcare
THC
$20.4B
$50.5M 4.3%
400,000
-130,000
-25% -$19.3M
BSX icon
3
Boston Scientific
BSX
$71.2B
$49.1M 4.19%
550,000
– –
VERA icon
4
Vera Therapeutics
VERA
$2.15B
$48.6M 4.15%
1,150,000
+650,000
+130% +$28.8M
CYTK icon
5
Cytokinetics
CYTK
$10.7B
$47M 4.01%
1,000,000
+250,000
+33% +$13M
INSM icon
6
CALL
Insmed
INSM
$21.4B
$34.5M 2.94%
+500,000
New +$36M
CNC icon
7
Centene
CNC
$31.7B
$30.3M 2.58%
+500,000
New +$31.2M
CAH icon
8
Cardinal Health
CAH
$54.7B
$29.6M 2.52%
+250,000
New +$29.2M
LLY icon
9
Eli Lilly
LLY
$997B
$29.3M 2.5%
38,000
+28,000
+280% +$23.2M
EHC icon
10
Encompass Health
EHC
$11B
$27.7M 2.36%
300,000
+25,000
+9% +$2.45M
RVMD icon
11
Revolution Medicines
RVMD
$41.1B
$24.1M 2.05%
550,000
+200,000
+57% +$10.1M
BPMC
12
DELISTED
Blueprint Medicines
BPMC
$24M 2.04%
275,000
-15,000
-5% -$1.37M
CVS icon
13
CVS Health
CVS
$133B
$22.4M 1.91%
+500,000
New +$28.1M
NBIX icon
14
Neurocrine Biosciences
NBIX
$16.9B
$21.8M 1.86%
+160,000
New +$19.8M
ISRG icon
15
Intuitive Surgical
ISRG
$130B
$20.9M 1.78%
+40,000
New +$20.8M
MCK icon
16
McKesson
MCK
$97.2B
$19.9M 1.7%
+35,000
New +$19.6M
MRK icon
17
Merck
MRK
$316B
$19.9M 1.7%
200,000
– –
BMY icon
18
Bristol-Myers Squibb
BMY
$135B
$19.8M 1.69%
350,000
+175,000
+100% +$9.78M
DGX icon
19
Quest Diagnostics
DGX
$25.8B
$19.6M 1.67%
130,000
+10,000
+8% +$1.56M
QURE icon
20
uniQure
QURE
$3.03B
$19.4M 1.66%
1,100,000
+700,000
+175% +$6.04M
TARS icon
21
Tarsus Pharmaceuticals
TARS
$2.66B
$19.4M 1.65%
350,000
-25,000
-7% -$1.14M
INSP icon
22
Inspire Medical Systems
INSP
$1.85B
$18.5M 1.58%
100,000
-60,000
-38% -$11.6M
GILD icon
23
Gilead Sciences
GILD
$168B
$18.5M 1.57%
+200,000
New +$18M
NARI
24
DELISTED
Inari Medical, Inc. Common Stock
NARI
$17.9M 1.52%
350,000
-50,000
-13% -$2.46M
SRRK icon
25
Scholar Rock
SRRK
$5.73B
$16.2M 1.38%
375,000
+100,000
+36% +$3.26M
1
2 3 4 5

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.09B AUM 33.67% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

Integral Health Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Integral Health Asset Management held 102 positions worth $1.17B, up 32% from $889M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Integral Health Asset Management deployed $340M of net new capital in Q4 2024, opening 36 new positions and adding to 28 existing holdings. Its largest new stake was Centene: 500,000 shares worth $30.3M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier.

On the sell side, the largest reduction was Tenet Healthcare, an estimated $19.3M trimmed.

  • Integral Health Asset Management's largest Q4 2024 buy was Centene: 500,000 shares worth $30.3M.
  • Integral Health Asset Management added most to Vera Therapeutics in Q4 2024, an estimated $28.8M increase.
  • Integral Health Asset Management's biggest Q4 2024 reduction was Tenet Healthcare, cutting an estimated $19.3M.
  • Integral Health Asset Management fully exited Longboard Pharmaceuticals, Inc. Common Stock in Q4 2024, selling an estimated $35M.
  • Integral Health Asset Management's ten largest holdings make up 39% of its $1.17B portfolio in Q4 2024.
  • Integral Health Asset Management opened 36 new positions and closed 19 in Q4 2024.
  • Integral Health Asset Management's portfolio value rose 32% quarter-over-quarter to $1.17B.

Based on Integral Health Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.